EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia

Seongheon Lee, Dongho Kang, Eunjin Song, Sungah Yoo, Seongwook Jeong

BMC Anesthesiology · 2024

DOI: 10.1186/s12871-024-02461-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Anesthesiology, 2024. Verfasst von Seongheon Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Chonnam University Hospital, Gwangju, South Korea. Hauptthemen laut MEDLINE: Propofol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daewon Pharmaceutical Co Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Propofol formulated with medium- and long-chain triglycerides (MCT/LCT propofol) has rapidly replaced propofol formulated with long-chain triglycerides (LCT propofol). Despite this shift, the modified Marsh and Schnider pharmacokinetic models developed using LCT propofol are still widely used for target-controlled infusion (TCI) of propofol. This study aimed to validate the external applicability of these models by evaluating their predictive performance during TCI of MCT/LCT propofol in general anesthesia.

Methods

Adult patients ( n = 48) undergoing elective surgery received MCT/LCT propofol via a TCI system using either the modified Marsh or Schnider models. Blood samples were collected at various target propofol concentrations and at specific time points, including the loss of consciousness and the recovery of consciousness (13 samples per patient). The actual plasma concentration of propofol was determined using high-performance liquid chromatography. The predictive performance of each pharmacokinetic model was assessed by calculating four parameters: inaccuracy, bias, divergence, and wobble.

Results

Both the modified Marsh and Schnider models demonstrated predictive performances within clinically acceptable ranges for MCT/LCT propofol. The inaccuracy values were 24.4% for the modified Marsh model and 26.9% for the Schnider model. Both models showed an overall positive bias, 16.4% for the modified Marsh model and 16.6% for the Schnider model. The predictive performance of MCT/LCT propofol was comparable to that of LCT propofol, suggesting formulation changes might exert only a minor impact on the reliability of the TCI system during general anesthesia. Additionally, both models exhibited higher bias and inaccuracy at target concentrations ranging from 3.5 ~ 5 ug/ml than at concentrations between 2 ~ 3 ug/ml.

Conclusions

The modified Marsh and Schnider models, initially developed for LCT propofol, remain clinically acceptable for TCI with MCT/LCT propofol.

Trial registration

This study was registered at the Clinical Research Information Service of the Korean National Institute of Health ( https://cris.nih.go.kr ; registration number: KCT0002191; 06/01/2017).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolAdultHumansAnesthetics, IntravenousReproducibility of ResultsWetlandsInfusions, IntravenousAnesthesia, GeneralTriglycerides

Stichwörter der Autor:innen

External validationMarsh modelPropofol formulationSchnider modelTarget controlled infusion

Substanzen

PropofolAnesthetics, IntravenousTriglycerides

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Chonnam University Hospital, Gwangju, South Korea.
  • Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, 160, Baekseo-ro, Dong-gu, Gwangju, South Korea.
  • Department of Anesthesiology and Pain Medicine, Chonnam University Hospital, Gwangju, South Korea. anesman@gmail.com.
  • Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, 160, Baekseo-ro, Dong-gu, Gwangju, South Korea. anesman@gmail.com.

Förderung

  • Daewon Pharmaceutical Co Ltd

Zitieren

APA

Lee, S., Kang, D., Song, E., Yoo, S., & Jeong, S. (2024). External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia. BMC Anesthesiology. https://doi.org/10.1186/s12871-024-02461-5

Vancouver

Lee S, Kang D, Song E, Yoo S, Jeong S. External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia. BMC Anesthesiology. 2024. doi:10.1186/s12871-024-02461-5

BibTeX
@article{Lee2024,
  author = {Lee, Seongheon and Kang, Dongho and Song, Eunjin and Yoo, Sungah and Jeong, Seongwook},
  title = {External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia},
  journal = {BMC Anesthesiology},
  year = {2024},
  doi = {10.1186/s12871-024-02461-5}
}
Kostenlos starten →